CD8A and glioblastoma: Our recent work did not identify differences in the percentage of CD69 and IFNγ positivity in unstimulated peripheral CD4+ and CD8+ T cells and NK cells from newly diagnosed glioblastoma patients versus healthy donors potentially due to the expected low levels of CD69 and IFNγ positivity when cells were unstimulated.